For the Controlled Drug Reporting (CDR) website — cdreporting.co.uk
This accessibility statement applies to the Controlled Drug Reporting (CDR) website at www.cdreporting.co.uk, which is operated on behalf of NHS England by the Controlled Drugs Accountable Officer team.
We want as many people as possible to be able to use this website. For example, that means you should be able to:
We’ve also made the website text as simple as possible to understand.
AbilityNet has advice on making your device easier to use if you have a disability.
We know some parts of this website are not fully accessible:
If you need information on this website in a different format, such as accessible PDF, large print, easy read, audio recording or braille, please email the team using the contact details on our contact page. We’ll consider your request and aim to reply within 5 working days.
We’re always looking to improve the accessibility of this website. If you find any problems not listed on this page, or think we’re not meeting the accessibility requirements, please contact us via the contact page.
The Equality and Human Rights Commission (EHRC) is responsible for enforcing the Public Sector Bodies (Websites and Mobile Applications) (No. 2) Accessibility Regulations 2018 (the ‘accessibility regulations’). If you’re not happy with how we respond to your complaint, contact the Equality Advisory and Support Service (EASS).
NHS England is committed to making its websites accessible, in accordance with the Public Sector Bodies (Websites and Mobile Applications) (No. 2) Accessibility Regulations 2018.
This website is partially compliant with the Web Content Accessibility Guidelines version 2.1 AA standard, due to the non-compliances listed above.
The content listed below is non-accessible for the following reasons:
We aim to address the issues above as part of a continuous improvement programme.
This website is regularly reviewed by the development team using a combination of automated tools and manual checks against the WCAG 2.1 AA standard.
We are committed to a programme of continual improvement. Identified issues are tracked internally and prioritised alongside other site improvements.
This statement was prepared on 7 October 2026. It was last reviewed on 7 October 2026.